Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alexza Pharmaceuticals, Inc.
With
Celerion
A Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetic Profile of Staccato Granisetron (AZ-010) in Healthy Volunteers
Age
18–60
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy based on a medical evaluation including history, physical examination, vital signs, electrocardiograms (ECGs) and laboratory tests assessed at the screening visit and prior to the first dose of study drug.
Body weight ≥ 50 kg and BMI within the range of 18 to 32 kg/m2, inclusive, at screening.
Negative urine tests for selected drugs of abuse and alcohol breath test at screening and Day 1.
